POLYPEPTIDE VESICLES FOR INTRACELLULAR DRUG DELIVERY
UCLA Technology Available For Licensing

BACKGROUND:  Polymeric vesicles are a new class of nanoscale self-assembled materials that show great promise in drug delivery applications. Compared to liposomes, polypeptide vesicles have increased stability and can respond to external stimuli.

INNOVATION:  UCLA researchers have developed polypeptide vesicles of a particular composition that have the ability to entrap a water soluble species and transport the cargo across the cell membrane. The invention does not require chemical conjugation for the delivery of the drug of interest, resulting in a more cost effective formulation. This invention incorporates a patented manufacturing process also held by the University of California. The methods used allow for the control of the size of vesicles and scalability of the final product. Currently, researchers can create vesicles with diameters ranging from 50 to 1000nm that are stable up to 80 °C. Researchers have completed in vitro studies demonstrating the ability of polypeptide vesicles to cross the cell membrane intact.

POTENTIAL APPLICATIONS 

ADVANTAGES

Related Papers (Selected)
  • Polyarginine segments in block copolypeptides drive both vesicular assembly and intracellular delivery.  more...


Reference: UCLA Case No. 2007-014

For additional technical details and current licensing
availability, please contact the following UCLA office:

UCLA Office of Intellectual Property
11000 Kinross Avenue, Suite #200
Los Angeles, CA 90095-7231
Tel: 310-794-0558 Fax: 310-794-0638
email: ncd@research.ucla.edu
NCD URL:   http://www.research.ucla.edu/tech/ucla07-014.htm

Lead Inventor: Timothy Deming

UCLA Technologies Available for Licensing
http://www.research.ucla.edu/oipa/industry

Copyright © 2006 The Regents of the University of California.

keywords: therapeutics uclancd ucla technologies intellectual property patents technology transfer invention business card